Maynard Um
-
-
-
-
-
-
-
Wolfe Research Assumes Natera (NTRA) at Outperform
-
-
-
-
-
-
-
FDA approves Genentech's Tecentriq for bladder cancer treatment
-
-
-
-
-
-
-
Natera studies show Signatera test predicts cancer recurrence risk
-
-
-
-
-
-
-
Natera completes enrollment in heart transplant trial testing blood-based monitoring
-
-
-
-
-
-
-
Natera reports significant survival benefit in ALTAIR colorectal cancer trial
-
-
-
-
-
-
-
Natera (NTRA) files for 1.95M share offering by selling stockholders
-
-
-
-
-
-
-
Natera (NTRA) Misses Q3 EPS by 27c; offers guidance
-
406,346 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

